HomeAI · summaries
Storia in 11 fonti
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding
Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak in Africa. The vaccine uses technology similar to the Oxford-AstraZeneca Covid-19 vaccine. This partnership aims to accelerate development and ensure access for affected nations.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
euronews.com
Health body fast-tracks three Ebola vaccines as virus continues spread
Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.
- ·
koreatimes.co.kr
Moderna and other groups get $60 million to develop Ebola vaccine - The Korea Times
Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...
